![Tingzhi Qian](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tingzhi Qian
No más puestos en curso
Historial de carrera de Tingzhi Qian
Antiguos cargos conocidos de Tingzhi Qian.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Shanghai Fosun High-Tech Group Finance Co., Ltd.
![]() Shanghai Fosun High-Tech Group Finance Co., Ltd. Financial ConglomeratesFinance Fosun Group Finance Corp., Ltd. provides financial products and services. Its services include financial consulting, guarantee and payment services for member units, insurance agency, entrusted loans and entrusted investments, bills acceptance and discounting, factoring, interbank lending, and fixed income investments. The company was founded in June 2011 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 01/01/2008 | 01/01/2013 |
XYNOMIC PHARMACEUTICALS HOLDINGS, INC. | Director/Miembro de la Junta | - | - |
Formación de Tingzhi Qian.
École des Hautes Études Commerciales de Paris | Graduate Degree |
Polytech Clermont-Ferrand | Graduate Degree |
Fudan University | Undergraduate Degree |
Estadísticas
Internacional
China | 4 |
Francia | 3 |
Operativa
Graduate Degree | 2 |
Director/Board Member | 1 |
Corporate Officer/Principal | 1 |
Sectorial
Consumer Services | 4 |
Health Technology | 2 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Xynomic Pharmaceuticals Holdings, Inc.
![]() Xynomic Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Xynomic Pharmaceuticals Holdings, Inc. is a clinical stage best-in-class oncology therapeutics biopharmaceutical company. It engages in licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. Its current pipeline mainly consists of 3 drug candidates; Xynomic owns global exclusive development, manufacturing and commercialization rights to each of these. Its lead drug candidate abexinostat is in global potentially pivotal clinical trials against renal cell carcinoma and non-Hodgkin's lymphoma. The company was founded by Yinglin Mark Xu on October 7, 2016 and is headquartered in Shanghai, China. | Health Technology |
Shanghai Fosun High-Tech Group Finance Co., Ltd.
![]() Shanghai Fosun High-Tech Group Finance Co., Ltd. Financial ConglomeratesFinance Fosun Group Finance Corp., Ltd. provides financial products and services. Its services include financial consulting, guarantee and payment services for member units, insurance agency, entrusted loans and entrusted investments, bills acceptance and discounting, factoring, interbank lending, and fixed income investments. The company was founded in June 2011 and is headquartered in Shanghai, China. | Finance |
- Bolsa de valores
- Insiders
- Tingzhi Qian
- Experiencia